Condition

Tuberculosis, Pulmonary clinical trials and research

• 17Clinical trials
• 22Countries

Newest Tuberculosis, Pulmonary clinical trials

All recruiting trials (17)

• FAP PET/CT in adults with pulmonary TB

  This early-phase study tests whether a FAP PET/CT scan can map lung fibrosis in adults with pulmonary TB before starting treatment and after cure.

  Recruiting Early Phase 1 University of Pennsylvania · Philadelphia, Pennsylvania · NCT07830771

• Sorfequiline-based regimens for adults with newly diagnosed drug-sensitive pulmonary TB

  This study tests two sorfequiline-containing regimens, each with pretomanid and linezolid, to see if they are safe and effective in adults with newly diagnosed drug-sensitive pulmonary TB.

  Recruiting at 6 sites Phase 2 Global Alliance for TB Drug Development · Wentworth, Durban and 11 other locations · NCT07672405

• Digital health tool to help more people start TB preventive therapy

  A digital health approach is being tested to see if it helps household and close contacts of people with drug-sensitive pulmonary TB start TB preventive therapy better.

  Recruiting at 8 sites Arba Minch University · Arba Minch, South Ethiopia and 13 other locations · NCT07313995

• Ear acupuncture to reduce nausea and vomiting from tuberculosis medicines

  This trial will test whether press-needle ear acupuncture can reduce nausea and vomiting in people taking medicines for pulmonary tuberculosis.

  Recruiting Universitas Indonesia · Jakarta, Jakarta Timur · NCT07271225

• 18F-FAPI-74 PET imaging for lung fibrosis in tuberculosis

  This project tries to see if 18F-FAPI-74 PET scans can detect lung fibrosis in adults with active or recently treated tuberculosis.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07077213

• Blood TB DNA test to track treatment progress

  This project will test whether levels of TB-derived cell-free DNA in the blood can track treatment response in adults newly diagnosed with tuberculosis.

  Recruiting University of Oxford · Tak · NCT06845618

• ID93+GLA‑SE vaccine for tuberculosis prevention in adults 55–74

  This study will try three doses of the ID93+GLA‑SE vaccine to see if they are safe and boost immune responses in BCG‑vaccinated adults aged 55–74 compared with a saline placebo.

  Recruiting at 4 sites Phase 1 Quratis Inc. · Gwangmyeong, Gyeonggi-do and 3 other locations · NCT06714513

• Screening for tuberculosis in high-risk groups in Barcelona

  This study is trying to find and test people in high-risk groups in Barcelona for tuberculosis to help catch and treat the disease early.

  Recruiting Fundació Institut Germans Trias i Pujol · Badalona · NCT06706596

• Individualised model-informed dosing for pulmonary tuberculosis

  This project will test whether using model-informed precision dosing (MIPD) early in treatment helps clinicians get TB drug levels into the right range for adults with pulmonary tuberculosis.

  Recruiting at 2 sites Karolinska Institutet · Linköping and 1 other locations · NCT06585358

• Using Doxycycline to Prevent Lung Fibrosis in Tuberculosis Patients

  This study is testing if doxycycline can help prevent lung damage in people with advanced tuberculosis while they receive standard treatment.

  Recruiting Phase 2 Makerere University · Kampala, Kampala and 1 other locations · NCT06477185

• Stratified BPaLM treatment strategies for rifampicin-resistant pulmonary tuberculosis.

  This trial tests whether shorter BPaLM regimens (13- or 17-week courses) can work as well as the usual 24-week regimen for people aged 14 and older with fluoroquinolone-susceptible multidrug-resistant/rifampicin-resistant pulmonary TB.

  Recruiting at 4 sites Phase 2/3 University of California, San Francisco · Ulaanbaatar and 5 other locations · NCT06441006

• Shortened treatment for tuberculosis in children

  This study is testing if a shorter 2-month treatment for tuberculosis works just as well and is safe for children under 10 as the usual 4- to 6-month treatment.

  Recruiting at 9 sites Phase 3 Johns Hopkins University · Chennai and 8 other locations · NCT06253715

• Comparing high and standard doses of rifampicin for tuberculosis treatment

  This study is testing whether a higher dose of rifampicin can help people with pulmonary tuberculosis get better without causing more side effects compared to the standard lower doses.

  Recruiting at 2 sites Phase 3 Radboud University Medical Center · Turin and 1 other locations · NCT06057519

• Examining Latent Tuberculosis Infection in Health-care Workers and Students

  This study looks at how many health care workers and students have Latent Tuberculosis Infection without symptoms and what factors might put them at risk.

  Recruiting Catholic University of the Sacred Heart · Roma · NCT05756582

• Cohort of tuberculosis patients at Avicenne Hospital

  This study is trying to gather information from tuberculosis patients at Avicenne Hospital to understand their treatment results and find ways to improve care for those with the disease.

  Recruiting Assistance Publique - Hôpitaux de Paris · Bobigny and 1 other locations · NCT05539014

• Optimizing rifapentine treatment for drug-sensitive tuberculosis

  This study is testing a higher dose of rifapentine to see if it can effectively treat drug-sensitive tuberculosis in just 17 weeks, making it easier for patients to stick to their treatment.

  Recruiting Phase 2/3 Huashan Hospital · Guiyang, Guizhou and 5 other locations · NCT05401071

• Using atorvastatin to reduce lung inflammation after tuberculosis treatment

  This study is testing if atorvastatin, a cholesterol-lowering drug, can help adults who have finished tuberculosis treatment by reducing lingering lung inflammation.

  Recruiting Phase 2/3 University of Cape Town · Observatory, WC · NCT04147286

Related topics

Quick answers

How many Tuberculosis, Pulmonary clinical trials are recruiting right now?

17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 22 countries. The most sites are in Uganda (3 trials), South Africa (3 trials), United States (2 trials), Italy (2 trials), Indonesia (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 3, Phase 2: 2, Phase 3: 2, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →